How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries? – Research Paper – 15930156677
Search
Essays
Sign up
Sign in
Contact us
Tweet
Index
/Social Issues
How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries?
[pic 1]MGF5030 – Corporate Social ResponsibilityANZAM ReportHow should GlaxoSmithKline enact CSR with regards to product testing in developing countries?Ms Melissa RauffRita Gabrial (24156728)Monash University, Melbourne, AustraliaEmail: Rayees Ahmed S.R (27154998)Monash University, Melbourne, AustraliaEmail: Li Yongkun (26051788)Monash University, Melbourne, AustraliaEmail: Mengjie Ren (26241196Monash University, Melbourne, AustraliaEmail: )ABSTRACTThe treatment of people in less economically developed countries by major corporations has been widely debated and criticized internationally. One major criticism is the way healthcare is addressed and offered to people that need it most but do not have a means of getting it. The ways in which pharmaceutical giant, GlaxoSmithKline (GSK) should enact CSR in regards to testing drugs in developing countries will be examined in this report. The way that GSK targets poorer people to trial medicines, have more power than many governments, and will maximize profits at any costs will be discussed through relevant literature. The current issue of GSK trialing their drugs on people in developing countries will be looked at and discussed using secondary sources. This paper will recommend that CSR needs to be enacted by GSK investing in ethical-based procedures in their corporation, part of these procedures will include educating employees on the ethical dimension of working with people around the world. This paper will also recommend that GSK enforce very strict punishments to employees that take action that does not follow the GSK ethical procedures and breaks the law of developing countries. Keywords: Developing countries, testing, trialing, ethical-based procedures, educating employeesTable of ContentsABSTRACT 21.0 INTRODUCTION 52.0 LITERATURE REVIEW 62.1 Key Theories and Concepts 62.1.1 Stewardship Theory 62.1.2 Corporate-governance processes that are not controlled by weaker governments 72.1.3 Profit maximization at any cost 72.2 Arguments and Debates to consider 72.2.1 Vulnerable people 82.2.2 Family Consent to trial medicines 8
2.3 Current Procedures 82.3.1 GlaxoSmithKline’s current CSR practices 82.4 Conclusion 93.0 THE CASE 94.0 THE KEY ISSUES 104.1 Issues 1: Illiterate parents lacked an ability to make an informed decision regarding their involvement in the trials 104.2 Issues 2: GSK was able to unfairly influence a vulnerable Argentinian government 104.3 Issues 3: GSK have maximized profit with little regard to the welfare of trial participants 105.0 METHODOLOGY 116.0 RECOMMENDATIONS AND DISCUSSION 116.1 Ethical based procedures that adhere with human rights: 116.2 Being a billion dollar company they should exert social responsibility and prevent misuse of illiteracy in developing countries: 126.3 Pay compensation and to make sure it does not happen again: 137.0 CONCLUSION 138.0 LIMITATIONS OF THE STUDY 149.0 REFERENCES 151.0 INTRODUCTIONCorporate Social Responsibility (CSR) does not have a clear definition however; it can be understood to be a corporation’s or company’s moral responsibility to protect and better society in the present time and for the future by introducing social initiatives that have positive outcomes for the stakeholders that are involved (Mihalache, 2013). It can be understood from tis definition that all corporations have the responsibility to be more socially responsible and can be socially positive in their community. This leads us to the pharmaceutical industry whose purpose is to create and distribute drugs across the world. While this may seem to be socially responsible in itself, as consumers have a chance of receiving better health, there is another darker side to the pharmaceutical industry in regards to trialing new drugs and the procedures they should comply. This research paper will look at analyzing how GlaxoSmithKline (GSK) can enact CSR in regards to product testing in developing countries. To do this, secondary research will be collected and examined in order to discuss the particular case of GSK trialing drugs in Argentina that eventually lead to the death of 14 babies. Initially, the authors of this paper will create literature review in order to discuss current existing CSR approaches that are relevant to the topic as well as related theories, evidence and concepts that will help create this report. The literature review will allow the authors of this report to create recommendation to GSK in regards to how they can implement CSR for the issue that is discussed in this report. The purpose of this paper is to give GSK clear recommendations in regards to how CSR should be enacted to the specific issues that will be listed in this report.
Continue for 16 more pages »
Read full document
Download as (for upgraded members)
Citation Generator
MLA 7
CHICAGO
(2017, 05). How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries?. EssaysForStudent.com. Retrieved 05, 2017, from
“How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries?” EssaysForStudent.com. 05 2017. 2017. 05 2017 < "How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries?." EssaysForStudent.com. EssaysForStudent.com, 05 2017. Web. 05 2017. < "How Should Glaxosmithkline Enact Csr with Regards to Product Testing in Developing Countries?." EssaysForStudent.com. 05, 2017. Accessed 05, 2017. Essay Preview By: 15930156677 Submitted: May 20, 2017 Essay Length: 4,213 Words / 17 Pages Paper type: Research Paper Views: 416 Report this essay Tweet Related Essays Grounded Theory Study of Unethical Labour Practices Associated with Global Brands in Developing Countries (2006, 2845 words, 80%) Abstract This is a grounded theory study about unethical labour practices associated with global brands’ operations in developing countries. The research 585 Words | 3 Pages Medical Products Inc.: Developing New Products for the Twenty-First Century Medical Products Inc.: Developing New Products for the Twenty-First Century Synopsis MPI markets medical products and services as well as offers medical support products to 1,471 Words | 6 Pages Globalization Can Have a Negative Impact on Developing Countries. Argue. Globalization, the emergence of a global society in which economic, political, environmental and cultural events in one part of the world quickly come to have 368 Words | 2 Pages Developing Countries Gain from Trade Liberalization 4. Developing countries gain from trade liberalization Developing countries do have much to gain from general trade liberalization. Trade expansion is positively linked to growth. 941 Words | 4 Pages Similar Topics GlobalizationS Impacts Developing Countries Case Trade Liberalization Developing Countries Get Access to 89,000+ Essays and Term Papers Join 209,000+ Other Students High Quality Essays and Documents Sign up © 2008–2020 EssaysForStudent.comFree Essays, Book Reports, Term Papers and Research Papers Essays Sign up Sign in Contact us Site Map Privacy Policy Terms of Service Facebook Twitter